Morimoto Haruki, Ajiki Tetsuo, Takase Shiro, Fujita Tsunenori, Matsumoto Taku, Mita Yoshiyasu, Matsumoto Ippei, Fujino Yasuhiro, Suzuki Yasuyuki, Kuroda Yoshikazu, Ku Yonson
Department of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medical Sciences, Kobe, 650-0017, Japan.
J Hepatobiliary Pancreat Surg. 2008;15(6):655-8. doi: 10.1007/s00534-007-1311-9. Epub 2008 Nov 7.
A 69-year-old man diagnosed as having gallbladder cancer with liver invasion and metastasis to Couinaud's hepatic segment 8 (S8) was referred to our hospital. Because of the presence of liver metastasis, gemcitabine administration was chosen. Although gemcitabine was effective for the liver metastasis, his serum carcinoembryonic antigen (CEA) level had gradually increased after 12 cycles of gemcitabine administration. There was no distant metastasis other than the liver metastasis (manageable with gemcitabine) on detailed radiological examination. Therefore, we performed surgery for the primary lesion, after obtaining informed consent. Pathological examination demonstrated viable cancer cells with necrosis and fibrosis in the gallbladder, and fibrosis without viable cancer cells in the induration in liver S8. Gemcitabine was re-administered as postoperative adjuvant chemotherapy. Twenty months after the surgery, there was no sign of recurrence. In selected patients, gemcitabine treatment may be effective against gallbladder cancer with metastasis.
一名69岁男性被诊断为胆囊癌伴肝侵犯及转移至库氏肝段8(S8),转诊至我院。由于存在肝转移,选择了吉西他滨治疗。尽管吉西他滨对肝转移有效,但在接受12个周期吉西他滨治疗后,他的血清癌胚抗原(CEA)水平逐渐升高。详细的影像学检查显示,除肝转移(可用吉西他滨控制)外无远处转移。因此,在获得知情同意后,我们对原发灶进行了手术。病理检查显示,胆囊内有存活癌细胞伴坏死和纤维化,肝S8硬结处有纤维化但无存活癌细胞。术后辅助化疗重新使用了吉西他滨。手术后20个月,无复发迹象。在部分患者中,吉西他滨治疗可能对转移性胆囊癌有效。